In 2012, Matthew W. Emmens earned $497.18K in total compensation at Vertex Pharmaceuticals, primarily from $467.51K salary. Most recently sold 10,850 shares in Nov 2011. Led Vertex Pharmaceuticals as CEO for 2 years.
Compensation History
Annual executive compensation data for Matthew W. Emmens, including salary, bonuses, and stock awards.
Year
2012
Total Compensation
$497.18K
Salary
$467.51K
Bonus
$0.00
Other
$29.67K
Salary
$467.51KBoard Justification
The compensation program is designed to attract and motivate talented and experienced individuals, aligning their interests with those of shareholders.
Bonus
$0.00Board Justification
Mr. Emmens was not eligible for an annual cash bonus for 2012 performance.
Other Compensation
$29.67KBoard Justification
This includes board compensation received after his retirement from employment in May 2012.
Restricted Stock
Board Justification
Mr. Emmens did not receive any stock grants that vested in 2012.
Performance Metrics
The company's performance rating for 2012 was 'leading', with a score of 90% against its goals.
Matthew W. Emmens
Ex-CEO of Vertex Pharmaceuticals
Sector of Economy
Healthcare
CEO of Vertex Pharmaceuticals for
2 years 8 months (May 2009 - Feb 2012)
Previous Experience
CEO of Astra Merck, Inc., and of Shire plc
Holdings
Track Matthew W. Emmens's stock holdings and portfolio value over time.
Total Stock Sold
$988.21K
$988.21K
20,585 VRTX shares
What if they kept their stock?
If Matthew W. Emmens didn't sell their stock, today they would have:
Extra VRTX20,585 shares worth $9.41M.
This is 852.5% and $8.42M more than what they got when they sold the stock.
Insider Trading
Matthew W. Emmens's recent stock transactions, purchases, and sales filed with the SEC.
Rivals
Compare Matthew W. Emmens with competitor CEOs and industry peers.
Albert Bourla
CEO of Pfizer
2024 Compensation
Stock
$0.00
Salary
$1.80M
Bonus
$7.02M
Other
$996.06K
Total Holdings
$18.14M
Sundar Pichai
CEO of Alphabet Inc.
2024 Compensation
Stock
$51.70M
Salary
$2.02M
Bonus
$0.00
Other
$8.30M
Total Holdings
$399.66M
Andrew R. Jassy
CEO of Amazon
2024 Compensation
Stock
$38.48M
Salary
$365.00K
Bonus
$0.00
Other
$1.23M
Total Holdings
$2.14M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M
David A. Ricks
CEO of Eli Lilly
2024 Compensation
Stock
$0.00
Salary
$1.69M
Bonus
$5.71M
Other
$351.69K
Total Holdings
$468.86M